TheEdgeResearch
Home / Stocks / EXCL

Excellerant, Inc. (EXCL)

OTC Financial Services Shell Companies
$0.00 ▲ +0.00%
Market Cap
$1,130
Sector
Financial Services
Industry
Shell Companies
Beta
-7.07
52-Wk Range
0.000001-0.0002
CEO
Roman Kopinski
Country
BE
Currency
USD

Excellerant, Inc. operates in the Shell Companies industry of the Financial Services sector, headquartered in Brussels, BU, BE. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,130. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of 0.0%. Its beta of -7.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.03
Price / Sales
0.00
Price / Book
-0.06
EV / EBITDA
0.50
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.70
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2021-03-19
Headquarters
Brussels, BU, BE
About Excellerant, Inc.

Excellerant, Inc. is an emerging firm that offers diverse health-related consultation and travel coordination services to both corporate clients and private individuals. Its planned offerings encompass advisory services covering conventional and complementary medical practices, alongside advanced medical technologies. Furthermore, it aims to assist clients in selecting suitable treatment facilities, crafting detailed travel plans that incorporate clinics, hospitals, and other healthcare centers, and supplying guidance for prospective customers. The company also furnishes essential information regarding transportation logistics and healthcare providers. Established in 2019, this Brussels, Belgium-based entity operates as a subsidiary of Swamson Capital AG.

Comparable companies

Excellerant, Inc. is most often compared with the following Financial Services names:

AFHIFCCVLCKCBKSSHLRDRMUSSQUGBRYSMFSRUSTALC
More research on EXCL
EXCL technical analysis EXCL TheEdge Score Compare against peers
Open full interactive analysis & DCF →